Source: CNN & Company Pubdate: Wed, 17 Mar 1999 Feedback: http://www.cnn.com/feedback/ Forum: http://www.cnn.com/discussion/ Website: http://www.cnn.com/ REEFER MADNESS OR REEFER MEDICINE? Aired March 17, 1999 - 11:30 a.m. ET THIS IS A RUSH TRANSCRIPT. THIS COPY MAY NOT BE IN ITS FINAL FORM AND MAY BE UPDATED. MARY TILLOTSON, HOST: Reefer madness or reefer medicine? A new study out this morning on the medical use of marijuana. Thanks for joining us. I'm Mary Tillotson. About half an hour ago, an outfit called The Institute of Medicine, which is part of the National Academy of Sciences, released a new study on using marijuana as medicine. The study found that, yep, smoking marijuana can help some patients more than it hurts them, that it's not particularly addictive, that it does not lead users to try harder stuff like heroin, and there's no particular reason to believe medical use of marijuana will lead to more recreational use of the drug. The report confirms smoking marijuana can relieve patients who are nauseated and losing weight from AIDS or chemotherapy for cancer but the new study does not conclude those folks should be able to just pick up pot at the local drug store. Instead, the report wants doctors and pharmaceutical researchers to come up with a new delivery system that works as fast and effectively as smoking marijuana without the harmful side effects of inhaling that smoke. General Barry McCaffrey is head of the president's Office of National Drug Control Policy. He commissioned the medical marijuana study a year and a half ago. He's on the phone with us from Los Angeles. General McCaffrey, thank you for joining us. BARRY McCAFFREY, DRUG CONTROL POLICY DIRECTOR: Good to be here, Mary. TILLOTSON: This report is not exactly what you might have wished for, is it? McCAFFREY: We really think they've satisfied our requirements beautifully. Dr. John Benson and Dr. Stanley Watson that did this study really have moved this discussion where it belongs, back into the field of science and medicine. So let me just say unequivocally we thank them for their work. And they have contributed to a rational look at using canabanoids (ph) in research to find out whether they have utility to control some symptoms of certain diseases. TILLOTSON: Since both you and the Clinton administration, General, have been very much opposed to legalizing marijuana at the state level, which as you know has certainly happened in several states, does this in any way make you or do you think the administration in general rethink that position? McCAFFREY: No. I think really we're where we need to be. The study concludes there's little future on smoked marijuana as a medically approved medication. I don't think that's where the field is going. What may well be though, they've noted that advances in canabanoid science in the last 16 years opened a real wealth of new opportunities for development of some medically useful canabanoid- based drug. So I think where we'll need to -- what we'll need to do is what the National Institute of Health, Dr. Harold Varmis (ph), and people like Dr. Alan Leshner (ph) at NIDA (ph) look at this and determine what we can do to advance research on these potential symptom-controlling compounds. TILLOTSON: And so you think the idea of this mention in the study of finding a new delivery system such as an inhaler has some merit? McCAFFREY: Sure, absolutely. And I think on top of that, what they're really suggesting is that, you know, in the 1980s, THC, one of the most active of the canabanoids in smoked marijuana, was isolated is now available in pharmacies with a prescription from a doctor. And there may well be more of these canabanoid compounds that can be isolated and also could provide medical benefits. So the door should remain always open for evidence-based research on this or any other compound. TILLOTSON: General Barry McCaffrey, I understand out in Los Angeles you're going to have your own news conference responding to this in about half an hour, a little bit less? McCAFFREY: Indeed, Mary. TILLOTSON: We'll hear more from you then. Thank you, General McCaffrey. Joining our conversation now from New York, Richard Brookhiser. He is an author and senior editor at the "National Review." His latest book is "Alexander Hamilton, American." He's also, by the way, a former cancer patient and knows personally about the medical use of marijuana. Betty Sembler started the Drug Free America Foundation nearly 25 years ago in Florida. She's joining us from Miami this morning. And from Los Angeles, Dr. Ann Mohrbacher, who teaches at the University of Southern California and is in private practice as a cancer specialist. We are very glad to have all three of you here. Since you're the patient of the day, Richard, tell us about your own experience. You got familiar with the debate about medical marijuana and what it can or cannot do for chemotherapy patients when you were one of those back in 1992? RICHARD BROOKHISER, FORMER CANCER PATIENT: That's right. I was diagnosed with testicular cancer in 1992, and I underwent a course of chemotherapy that lasted over four months. And halfway through, I could tell that the legal anti-nausea drugs I was getting, which were the newest thing at the time, very good drugs, they were not going to continue to do the job. The effects of the chemotherapy were cumulative. So for the second half of my chemotherapy, I smoked marijuana. Now none of my doctors and none of my nurses discouraged me from doing this, and they'd all had experience with patients of theirs who had done this and who had gotten good results. And I was being treated at NYU Hospital in New York, and I had a consultation at Memorial Sloane Kettering (ph), so I was not going to New Age faith healers for this advice. TILLOTSON: Let me ask you this, Richard. I think a lot of people who are undergoing chemo or have AIDS, even if it's legal in their state, as is the case in California, the law is kind of murky, and they're scared to go out and buy the stuff. BROOKHISER: Well, and rightly so. I think one of the sad, sad aspects of our situation is that I was not at much risk. I live in Manhattan. I'm a journalist. I'm a lower rung of the media, a leat (ph) if you will. I'm not the kind of person who gets in trouble, but people are in different lines of work or live in different places, they can indeed get in trouble, particularly if they have a chronic condition and try to get pot repeatedly. TILLOTSON: I'm going to get back to you on the question of the oral pill versus smoking the stuff. Betty, it was your personal experience that got you involved in fighting drugs, too, was it not? One of your kids you were worried about? BETTY SEMBLER, DRUG FREE AMERICA FOUNDATION INC.: Absolutely. TILLOTSON: Tell us about that. SEMBLER: Well, it's been more than 25 years ago since I've entered the field, and yes, it was through one of my sons who was smoking marijuana. Of course, at the time, marijuana had much lower THC content than it does today. Today, there's about ten times the amount of this hallucinogenic drug in marijuana. So today, it's a much different drug than it was 25 years ago. But what that alerted me to was the danger to our children. So I have worked for the past 25 years teaching children and promoting the true information not only about marijuana but of course about all hallucinogenic and mind-altering drugs. TILLOTSON: I would think any parent would have to share your worry, but the report that's out this morning says there's no particular evidence that marijuana is what they're calling a gateway drug to encourage kids to go onto something else. And to be blunt with, Betty, when you've got an emaciated AIDS patient or somebody undergoing chemotherapy, this is scarcely the poster person for the kind of cool that teenagers want, is it? SEMBLER: Well, I think that -- Of course, I haven't read the complete report since it's only just been put out, but I have been able to read the synopsis of it. The recommendations validate what our message has been all along, that is Drug Free America Foundation. We have always supported scientific research, peer reviewed research, and FDA approval, and this report absolutely does not validate the smoking approved marijuana as medicine. What it does say is that there is plenty of room for research, something that we have always said. TILLOTSON: No, it does not validate the prescription of marijuana but what it does say is that it does not think that would lead to the sort of increased recreational use which is one of the primary arguments, is it not - -- and I'm going to go to Dr. Mohrbacher on this one -- against broadening the medicinal use of marijuana. The worry is will kids who aren't sick will somehow have broader access to it. DR. ANN MOHRBACHER, ASSISTANT PROFESSOR OF MEDICINE, UNIVERSITY OF SOUTHERN CALIFORNIA: Well, what is unorthodox about this situation is that this is a drug that patients or families could grow at home in other cases of legalizing medications based and provided by pharmaceutical companies or government sponsored trials. And I think some concern is that everyone would start growing a plot of marijuana and that other persons other than the patient would have access to it, and would that allow proliferation of use of the drug. TILLOTSON: I want to get to how it actually works in California where there is a state law that made it legal. But can we stick for just a moment -- and I'll start with Dr. Mohrbacher and then let Richard back in the conversation -- the pros and cons of taking the oral pill form of the effective agents in marijuana that supposedly suppress nausea form chemo or AIDS? I keep hearing patients say it's not as effective as smoking dope. MOHRBACHER: Well, that's the anecdotal information coming from the patients who have had some experience with the recreational use of the drug. The oral drug does work in some capacities. It is a rather modest anti-nausea agent compared to current drugs that we have available today, and I was curious whether Richard had one of the newer generation drugs that have really only been public for the past... TILLOTSON: Let's hear from him. BROOKHISER: Yeah, the drug I had was, oh, gee, I'm blanking on the name, but it was brand new in 1992, Zophran (ph). MOHRBACHER: Gophran (ph), exactly. BROOKHISER: I got Zophran which... MOHRBACHER: And that wasn't completely effective for you? BROOKHISER: No, it wasn't. It was effective at first, but then its effectiveness wore off. And look, there may be some patients who get a benefit from Marinol (ph). That's fine. MOHRBACHER: That's exactly true. BROOKHISER: That's fine. But then there are others who don't. And, you know, my doctors had years of research. My oncologist was the head of oncology at NYU Hospital. He'd seen lots of cancer patients, and a lot of them had gone the route of smoking marijuana to relieve their symptoms of nausea. Also, you know, I should say I wasn't a recreational smoker before, and I certainly never smoked recreationally after. You know, if you want to do aversion therapy for smoking marijuana, give everybody cancer, a course of chemotherapy, and give them some joints and they'll never look at one again. TILLOTSON: You gave us a lovely place to take a break, which we have to, unfortunately. We're going to be back, though, and talk about the intersection between politics and pot and whether it's really about medicine or about a political tug of war. Stay with us. Be right back. (COMMERCIAL BREAK) TILLOTSON: We're talking about a report that was put out this morning by a branch of the American Academy of Science talking about the fact that there is medical evidence now that smoking marijuana can help relieve the nausea of some AIDS and chemotherapy patients, but prescribing what may take years of research to come up with a new delivery system. Dr. Mohrbacher, they say smoking, taking the smoke into your lungs is bad for you in and of itself, so let's figure out how to do this with an inhaler for the speed and effectiveness of smoking marijuana without the bad side effects. How long could that sort of research take? MOHRBACHER: Oh, many years. And the number of exposures to the smoke are probably not very relevant from the medical point of view except in patients who are taking drugs that have long toxicity. And paradoxically, many of the patients who have asked me about whether it's OK to smoke marijuana or that they've heard it might be better than what I can offer as prescription drugs were younger patients. And those very patients are the ones who have Hodgkin's disease and testicular cancer where a drug called Liomycin (ph) is used which has intrinsic long toxicity. So I generally discouraged the idea only for fear that the smoking would somehow be interactive with the long toxicity of their drugs and ask them if they were interested in that category of drug being effective in them if they would please give a try to the prescription form of the active ingredient instead. And in general, many patients have to try a series of drugs on a trial and error basis to find out what works for them. And Richard is correct in that although 90 percent of patients would find relief from the more mainstream drugs, there will be a few patients who seem to uniquely benefit from that category of drug, and we do have a prescription form available. But I think many physicians don't doubt that there may be other active ingredients in the natural form of the drug that probably should be researched, but may be available in the smoked form of the drug or at least in the natural form of the drug in some fashion. BROOKHISER: That's right. And, you know, one thing I noticed in my own experience, and this is borne out by the testimony of other people who have used the smoke form of the drug, is that it's easier to titrate your own dose. It's much easier to control how much you need versus taking a pill because a pill is longer acting. You actually end up taking smaller amounts of it if you're, you know, doing it yourself on a kind of half or quarter joint basis per every wave of nausea that you feel. And this gets to the political point of why it should be that the government should be dictating these health decisions to doctors and patients. And this is where I feel that I as a conservative am not making not exception to my principles but I'm just following out their consequences. We were the people who ranted and raved about Hillary Clinton's health care plan, you know, because it was going to tell doctors and patients what they had to do and on and on and on. So why should most conservatives be opposed to this, which unfortunately they are? I just want to say to them, you know, come on, wake up, follow out your true principles. TILLOTSON: I want to let Betty back in real quickly because I want to emphasize to everybody, Betty, that your concern is to reduce if possible or at least not expand recreational use of illegal drugs. But why do you fear that medicinal use, if it were properly controlled and users had some kind of identification on them, would it encourage kids to use drugs? SEMBLER: Well, I certainly do not oppose the medical use of marijuana. What I do oppose and what the report certainly does point out is that the smoking of crude marijuana is not medicine. We must understand that. The peer review and scientific research is what I most heartily endorse. And I think that that's what all of us must realize. Naturally, if you call something a medicine and a child takes it, they can grow it, they can buy it, there's no control on it, there's no dosage recommendation, no quality control. That's not medicine. What medicine is is scientifically tested. You don't test anecdotes. You test the science of it. Once it is tested and properly tested, then... BROOKHISER: But, but... TILLOTSON: Richard, hang on to that. You're going to be first when we come back. Got to take one more break but before we do, we're going to hear from Rhonda Schaffler with an update from the New York Stock Exchange. (COMMERCIAL BREAK) TILLOTSON: Welcome back. Before we went to that break, I interrupted both Richard Brookhiser and Betty Sembler. SEMBLER: Yes. TILLOTSON: I'm going to start with you, Betty. You seem to be making the point, no such thing as smoking marijuana for medicinal purposes? SEMBLER: Well, I certainly don't believe so, especially crude marijuana. We know from our research community that smoking of anything poses a grave risk to the user. And marijuana, crude marijuana contains over 400 different chemicals that the user is inhaling. TILLOTSON: Academic if the user is already dying of cancer, isn't it? MOHRBACHER: Not always. Some of the patients are using this in curable cancers such as testicular cancer and Hodgkin's disease. BROOKHISER: Yeah, but look, medicines, lots of medicines that are scientifically tested are very dangerous, and they can be overused. SEMBLER: Yeah, I certainly do agree with that, Richard. BROOKHISER: There is abuse of prescription medicines all the time, but that doesn't mean we yank them off the shelves and it doesn't mean we don't let doctors use them. And you always have to weigh the benefits against the risks. I also think... SEMBLER: But we also have to have scientific evidence. BROOKHISER: I also think it was a little disingenuous, it was disingenuous of the drug tsar to begin our segment by saying, "We need more research" as if this IOM report was the first research that has ever been done. It's only the first research that he signed off on. There have been studies of various aspects of medical use of marijuana going back over 20 years. This is not a new thing, this is not a brand new discovery. This is something that patients -- This is something that... TILLOTSON: And I want to let Dr. Mohrbacher in. You're nodding your head yes. You're agreeing with Richard on that, right? MOHRBACHER: Yes. There is a... BROOKHISER: This is something that patients and doctors have known for a long time, and we haven't made use of it because of an extreme fear of marijuana as a maligned, magical substance that must not be used under any circumstances. (CROSSTALK) TILLOTSON: Dr. Mohrbacher, for the sake of truth in advertising, I want to say that it's been a long time now, but I watched my mother struggle through cancer and chemotherapy, and at the time, they gave her something I think I'm recalling correctly called the Brompton (ph) cocktail or a combination of all kinds of stuff that the police would have me in the slammer for buying on the street, and that was all right. But marijuana's not? MOHRBACHER: Well, I think the politicization of the issue is resting on the fact that it is an illicit drug first not a drug that had a medical indication first as in cocaine or other opiates that we would certainly never deny a cancer patient and would not claim is being spread as a recreational drug to a society just because it's made available for medical use. The other issue is it certainly has medical benefits. Whether any of those are attributable to the actual smoked form of it or not is not yet known. On the other hand, when we say further research needs to be done, how long will that take? And if the patient has, for example... TILLOTSON: And is that politicizing the discussion? MOHRBACHER: I believe so, because I think that a terminally ill patient with either AIDS or cancer isn't the going to wait five years until a purified form of this is available. On the other hand, it's relatively few cancer patients who are asking me for this in the smokable form. In fact, most of them have such negative associations with that that they wouldn't try it if they were pressed to. Some of my colleagues in the HIV field say that they've had quite numerous anecdotal reports of the smoke form working better than the pill form that we routinely offer, and that they found that patients together often encourage each other to try it, and that women patients in particular were often reluctant to because of the illicit nature of it. But some who had never used a recreational drug in their life did find the drug gave them significant relief. TILLOTSON: I think a quick answer... MOHRBACHER: My feeling is ultimately that it will not be the smoked form of it that's going to be recommended for medicinal use, but I have no idea how long it will take to do the research and develop those drugs or whether there's even any financial interest in developing these drugs. Remember, the government isn't going to provide it long term... TILLOTSON: You got votes coming up... MOHRBACHER: Some patients, some patients can't wait. TILLOTSON: You've got votes coming up in four more states and I'm curious - -- We're almost out of time, but I want to get an opinion from each of you since we got the report out today that in effect says, yes, there is some utility, though we don't like the delivery method of smoking the stuff. Do you think the report from the IOM, Richard -- and then I'm going to get Betty in and Dr. Mohrbacher in -- is going to increase the chances there will be more such state laws passed to allow the medicinal use of marijuana? BROOKHISER: Well, definitely. I think the people of America and the states have shown that they have a better sense of this issue than the politicians in Washington. They'll continue to do so. TILLOTSON: And Betty? SEMBLER: Well, I certainly don't think that we should vote by medicine, you know, these ballot initiatives. We've never voted on medicines in this country. We have a device called the FDA. TILLOTSON: I think we vote on what's bad though. I remember prohibition. Wasn't that one? SEMBLER: Well, that's of course a whole other program if you'd like to go into it. But the recommendations from the IOM do not recommend a long-term study. However, it does... TILLOTSON: I'm so sorry, we needed more time always. Betty, next time. Yes, we'll come back and discuss this and... SEMBLER: Yes, I'll be happy to come back. TILLOTSON: ... prohibition as well. Appreciate our guests coming in today. SEMBLER: Thank you. TILLOTSON: Dr. Ann Mohrbacher, Betty Sembler, Richard Brookhiser, good to have the three of you. Glad as always everybody else was with us, too. Hope to see you tomorrow. I'm Mary Tillotson. - --- MAP posted-by: Richard Lake